Full article: Comparative efficacy of omalizumab, dupilumab, and remibrutinib in chronic spontaneous urticaria: a network meta-analysis of randomized control trials https://t.co/3PeWQovQTo
Efficacy of oral isotretinoin monotherapy compared to combination isotretinoin and topical clascoterone for severe acne vulgaris: a multi-center retrospective study: Journal of Dermatological Treatment: Vol 36, No 1 https://t.co/PldVwm07xk
Efficacy of oral isotretinoin monotherapy compared to combination isotretinoin and topical clascoterone for severe acne vulgaris: a multi-center retrospective study: Journal of Dermatological Treatment: Vol 36, No 1 https://t.co/q1kuOsgcbF
In this episode of #JCMS Author Interviews Podcast, JCMS Editor-in-Chief Dr. Kirk Barber is joined by @Mo_derm to talk about his May/June article, “Low Dose Oral Alitretinoin with Narrowband Ultraviolet B Therapy for Chronic Hand Dermatitis." https://t.co/DMLD73Xu1S
I am deeply concerned about images, videos, and targeted threats of violence against the Muslim community in India.
The Modi govt must stop stoking anti-Muslim sentiment.
Human rights must be protected.
Canada must play a strong role in working towards peace everywhere.
CMAJ is sorry for the harm caused by the publication yesterday of a letter, the headline of which suggested the hijab is an instrument of oppression of Muslim women. We are listening carefully to the critical feedback we’ve received.
Terrifying details. Police say the Imam's family hid from the suspect behind bushes, he SEARCHED for them. Once he found them he threatened to kill them. #HamOnt
The extent to which @US_FDA is willing to violate its own standards and protocols in order to approve a drug that has failed clinical trials makes one thing clear:
Regulatory capture of the FDA by the drug industry is more complete than even I expected.
https://t.co/LOLOoOSuxE